A carregar...
Glucose or Insulin, Which Is the Culprit in Patients with COVID-19 and Diabetes?
Patients with a metabolic syndrome (overweight, diabetes, hypertension, and dyslipidemia) have a particularly bad outcome if infected with SARS-CoV-2. Yu et al. (2020) suggest that insulin therapy itself may promote fatality in patients with COVID-19 and diabetes.
Na minha lista:
| Publicado no: | Cell Metab |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7685630/ https://ncbi.nlm.nih.gov/pubmed/33248018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2020.11.015 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|